Olanzapine in Patients With Borderline Personality Disorder

Clinical trial NCT00091650 · COMPLETED

Trial details

NCT number: NCT00091650
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Borderline Personality Disorder

Start date: 2004-03-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.